US FDA approves Lilly's once-weekly insulin injection for type 2 diabetes
- Posted on September 24, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
US FDA approves Lilly's once-weekly insulin injection for type 2 diabetes
Sept 24 (Reuters) - The US Food and Drug Administration has approved Eli Lilly's once-weekly basal insulin, Onswik, for adults with type 2 diabetes, the drugmaker said on Thursday, offering patients an alternative to daily long-acting insulin injections. Here are some details: • Onswik, chemically known as insulin efsitora alfa-gobe, is intended to be used alongside diet and exercise to control
